0,1,2,3,4,5,6
,,,B,,,
,,rEAV nsp5 Y113H+A134V,,,rEAV nsp5 Q21R+Y113H+A134V,
,,(EC50 of 9.1 (cid:4)M),,,(rEAVQYA; EC50 of 7.2 (cid:4)M),
,120,,,,120,
,,,,,,No virus
,,CsA-1,,,CsA-1,
,100,,,,100,rEAVwt
,,,,,,rEAV CsA-1 mutants
,80,,,,80,
,,,,,,rEAV CsA-2 mutant
(% to mock-infected cells),60,,Relative viability,(% to mock-infected cells),60,
,,,,,,rEAV CsA-3 mutant
,40,,,,40,
,20,,,,20,
